Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1907970 | 0.95 | TSHR (0.62) | TSHRALDH1A1TDP1CYP3A4LMNA | |
| SCHEMBL308987 | 0.95 | TSHR (0.55) | TSHRALDH1A1TDP1CYP3A4LMNA | |
| SCHEMBL25178030 | 0.93 | TSHR (0.56) | TSHRALDH1A1TDP1CYP3A4LMNA | |
| SCHEMBL25181783 | 0.93 | TSHR (0.56) | TSHRALDH1A1TDP1CYP3A4LMNA | |
| SCHEMBL9718866 | 0.91 | TSHR (0.60) | TSHRALDH1A1LMNADNM1PLA2G2C | |
| SCHEMBL25172413 | 0.91 | TSHR (0.60) | TSHRALDH1A1TDP1CYP3A4LMNA | |
| SCHEMBL25182423 | 0.91 | TSHR (0.60) | TSHRALDH1A1TDP1CYP3A4LMNA | |
| SCHEMBL25185574 | 0.91 | TSHR (0.60) | TSHRALDH1A1LMNADNM1PLA2G2C | |
| SCHEMBL25178838 | 0.91 | TSHR (0.50) | TSHRALDH1A1TDP1CYP3A4LMNA | |
| SCHEMBL25178120 | 0.91 | TSHR (0.58) | TSHRALDH1A1TDP1CYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE31812-E | TO ALDEHYDES IN PRESENCE OF CATALYTIC SYSTEM CONTAINING RHODIUM AND SULFONATED ARYL PHOSPHINE COMPOUND | RHONE-POULENC INDUSTRIES (FR) | 1985-01-22 | — | — | US | claimed |
| US-4248802-A | Catalytic hydroformylation of olefins | RHONE-POULENC INDUSTRIES (FR) | 1981-02-03 | — | — | US | claimed |
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| US-6995293-B2 | Method for the production of aldehydes | CELANESE CHEMICALS EUROPE GMBH (DE) | 2006-02-07 | — | — | US | disclosed |
| US-20050085671-A1 | Method for the production of aldehydes | DRACHENFELSSEE 521. VV GMBH (TO BE RENAMED OXEA DEUTSCHLAND GMBH) (DE) | 2005-04-21 | — | — | US | disclosed |
| EP-1390334-A2 | HYDROFORMYLATION PROCESS | Davy Process Technology Limited (GB) | 2004-02-25 | — | — | EP | disclosed |
| US-20020188160-A1 | The catalyst either water-soluble or carbon dioxide-soluble and the reaction product soluble in the phase in which the catalyst is insoluble, wherein the reaction products and catalyst can be readily separated by a phase separation | LOS ALAMOS NATIONAL SECURITY, LLC | 2002-12-12 | — | — | US | disclosed |
| WO-2002096848-A2 | HYDROFORMYLATION PROCESS | DAVY PROCESS TECHNOLOGY LIMITED (GB) | 2002-12-05 | — | — | WO | disclosed |
| US-6479708-B1 | The catalyst either water-soluble or carbon dioxide-soluble and the reaction product soluble in the phase in which the catalyst is insoluble, wherein the reaction products and catalyst can be readily separated by a phase separation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-11-12 | — | — | US | disclosed |
| US-6472565-B1 | Method for producing aldehydes | CELANESE CHEMICALS EUROPE GMBH (DE) | 2002-10-29 | — | — | US | disclosed |
| US-5118867-A | Hydroformylation of an definically unsaturated compound, rhodium catalyst, a soluble ammonium salt of a sulfonated phosphorous acid triester | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-06-02 | — | — | US | disclosed |
| US-5093297-A | Polystyrene immobilized rhodium complex catalyst for the hydroformylation of olefins | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1992-03-03 | — | — | US | disclosed |
| EP-0435084-A1 | Process for the production of aldehydes | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-07-03 | — | — | EP | disclosed |
| US-4889957-A | HYDROFORMYLATION OF UNSATURATED HYDROCARBONS | RHONE-POULENC CHIMIE DE BASE (FR) | 1989-12-26 | — | — | US | disclosed |
| US-4778905-A | WITH SULFONATED TRIARYLPHOSPHINE LIGAND | RHONE-POULENC CHIMIE DE BASE (FR) | 1988-10-18 | — | — | US | disclosed |
| US-RE31812-E | TO ALDEHYDES IN PRESENCE OF CATALYTIC SYSTEM CONTAINING RHODIUM AND SULFONATED ARYL PHOSPHINE COMPOUND | RHONE-POULENC INDUSTRIES (FR) | 1985-01-22 | — | — | US | disclosed |
| EP-0096987-A2 | Hydroformylation process | DAVY McKEE (LONDON) LIMITED (GB) | 1983-12-28 | — | — | EP | disclosed |
| EP-0096986-A2 | Hydroformylation process | DAVY McKEE (LONDON) LIMITED (GB) | 1983-12-28 | — | — | EP | disclosed |
| US-4248802-A | Catalytic hydroformylation of olefins | RHONE-POULENC INDUSTRIES (FR) | 1981-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020188160-A1 | The catalyst either water-soluble or carbon dioxide-soluble and the reaction product soluble in the phase in which the catalyst is insoluble, wherein the reaction products and catalyst can be readily separated by a phase separation | MED1, CD14, AP2S1 | TSHR 2599/4885ALDH1A1 4295/4885TDP1 3506/4885 |
| US-20050085671-A1 | Method for the production of aldehydes | ACSL3, ACSL5, TST | TSHR 3705/4885ALDH1A1 116/4885TDP1 4189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.